Charles River Laboratories has expanded its portfolio of support services for drug discovery, development and manufacturing with the launch of RightSource, a flexible insourcing/outsourcing solution for quality-control (QC) testing of biologics.
With the new service, Charles River can work with clients to review their QC testing programmes and determine the optimal, most cost-efficient combination of insourcing and outsourcing options.
Once the right externalisation model is identified, Charles River will be able to manage completely the client’s quality-control testing programme, evaluate and select outsourcing vendors where necessary, and provide a dedicated project manager to oversee all of the client’s QC activities.
Working on- or off-site, the project-management team can handle a range of activities including management of all QC testing, whether conducted in-house or outsourced; weekly status updates to all stakeholders; planning and forecasting of QC testing needs; co-ordination of shipping and associated paperwork; management of other outsourcing partners; and one-stop invoicing.
Risks and costs
The RightSource service enables pharmaceutical and biotechnology companies to reduce risk and costs by using their existing laboratories and staff while taking advantage of Charles River’s biosafety-testing expertise, the company pointed out.
“Growing demand for services such as RightSource points to the continued challenges biopharmaceutical companies face, as well as the increased reliance on drug-development partners like Charles River, particularly in the area of biologics,” commented Birgit Girshick, the company’s corporate senior vice president, research models and global biopharmaceutical services.
